Barclays’s LifePoint Health, Inc. LPNT Stock Holding History

Barclays’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,600	Closed	-$208K	–	7390
2017 Q3	$208K	Buy	+3,600	New	+$214K	﹤0.01%	4395
2017 Q2	–	Sell	-1,200	Closed	-$79K	–	7288
2017 Q1	$79K	Hold	1,200	–	–	﹤0.01%	5058
2016 Q4	$68K	Buy	+1,200	New	+$69.4K	﹤0.01%	4982
2015 Q3	–	Sell	-3,000	Closed	-$258K	–	7466
2015 Q2	$258K	Buy	3,000 +2,800	+1,400%	+$212K	﹤0.01%	3967
2015 Q1	$15K	Sell	200 -300	-60%	-$21.3K	﹤0.01%	6013
2014 Q4	$36K	Buy	500 +300	+150%	+$20.8K	﹤0.01%	5968
2014 Q3	$14K	Hold	200	–	–	﹤0.01%	6727
2014 Q2	$12K	Buy	+200	New	+$11.7K	﹤0.01%	6769
2014 Q1	–	Sell	-100	Closed	-$5K	–	8002
2013 Q4	$5K	Buy	+100	New	+$5.02K	﹤0.01%	7199

Other funds holding LPNT

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Barclays's LPNT Position: Q4 2018 in Review

Barclays sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 118,891 shares — an estimated $7.66M sold.

Barclays first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $7.66M in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

Barclays reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
Barclays sold 118,891 LifePoint Health, Inc. shares in Q4 2018, an estimated $7.66M.
Barclays first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
Barclays's LifePoint Health, Inc. position peaked at $7.66M in Q3 2018.
3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.